Sid
Senior Member (Voting Rights)
Exercise training is also effective for postural orthostatic tachycardia syndrome
The studies claiming that have huge dropout rates.
Exercise training is also effective for postural orthostatic tachycardia syndrome
There's a POTS clinic where i live. The head cardiologist insists that exercise is a treatment and has published studies on it. When patients say exercise makes them worse, they are told to take an SSRI and excluded from the study because he thinks PEM is a mental illness.The studies claiming that have huge dropout rates.
“We don’t know what the role of exercise is,” Durstenfeld said. “That’s why, scientifically, it’s really important that we study it in a rigorous fashion, especially when there are competing viewpoints in the community, where some people think exercise is extremely harmful and other people think exercise is the key to recovery.”
There's a POTS clinic where i live. The head cardiologist insists that exercise is a treatment and has published studies on it. When patients say exercise makes them worse, they are told to take an SSRI and excluded from the study because he thinks PEM is a mental illness.
Something can be very effective for some patients while being ineffective or harmful to others. I guess this paper is foundational for the claim of effectiveness: The International POTS Registry: Evaluating the Efficacy of an Exercise Training Intervention in a Community Setting (SciHub)The studies claiming that have huge dropout rates.
And don't seem any better than the ME ones. I keep hearing that about POTS but the evidence just isn't there. It's pretty clear that wherever actual POTS is concerned, not dysautonomia or orthostatic intolerance, time is the only factor and otherwise nothing really works, at least not any better than eating more salt. Just like with ME, it's built on fake positives and charlatans hyping their business, but isn't supported by data at all.The studies claiming that have huge dropout rates.
... wherever actual POTS is concerned, not dysautonomia or orthostatic intolerance
Johns Hopkins website said:POTS is a form of dysautonomia — a disorder of the autonomic nervous system. This branch of the nervous system regulates functions we don’t consciously control, such as heart rate, blood pressure, sweating and body temperature. The key characteristics of POTS are the specific symptoms and the exaggerated increase in heart rate when standing.
ninds.nih.gov website said:Postural orthostatic tachycardia syndrome (POTS) is one of a group of disorders that have orthostatic intolerance (OI) as their primary symptom. OI is a condition in which an excessively reduced volume of blood returns to the heart after an individual stands up from a lying down position. The primary symptom of OI is lightheadedness or fainting.
In POTS, the lightheadedness or fainting is also accompanied by a rapid increase in heartbeat of more than 30 beats per minute, or a heart rate that exceeds 120 beats per minute, within 10 minutes of rising. The faintness or lightheadedness of POTS is relieved by lying down again.
Rather than building on four decades of knowledge about PEM and ME/CFS, many of the appallingly slow studies on long COVID are repeating past mistakes. Most recently, the National Institutes of Health’s $500 million RECOVER study was criticized for focusing on exercise as a potential treatment for long COVID.
Expecting exercise to treat long COVID not only ignores the harm it could do to a majority of patients, it also neglects one of the distinguishing and most poorly understood traits of long COVID and ME/CFS.
Compounding the problem, the NIH has barely gotten any long COVID studies off the ground, despite $1 billion in federal funding, and it will not have findings for several more years. A search of the NIH’s clinical trials database, which includes registered studies in all 50 U.S. states and 221 countries, finds only 11 active studies on treatments for long COVID.
Of these, three are exercise trials and one applies cognitive behavioral therapy. Studies that are currently recruiting involve treatments such as self-management of symptoms and — from the Mayo Clinic — mindfulness through meditation. Only one study focuses on PEM specifically.
Since “long COVID” likely encompasses a variety of conditions triggered by COVID-19, a subset of patients might well benefit from exercise and meditation.
But just as no one would expect yoga to cure lupus, which can also be activated by viruses, these interventions cannot take the place of meaningful treatments for biomedical dysfunction.
I just mean meeting the arbitrary threshold of 30BPM increase. I'm not sure where the differences are, but there is a group of people whose heart rate just jumps like mad, I mean 150+ at the slightest exertion, can even stay there for hours.Can you expand on this?
My understanding is that POTS is a syndrome that falls under both of those umbrella terms - dysautonomia and orthostatic intolerance.
RECOVER's own study published today shows 87% of those they classify as having PASC/Long Covid have PEM. Those that don't are mostly in the subgroup dominated by loss of smell/taste.Relies on this for the "half of LC patients develop ME": Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC) > (S4ME) a whole 140 non selective subjects !
“The Office of Long COVID Research and Practice will enhance efforts being undertaken across the U.S. government to improve the lives of those who continue to experience the long-term impacts of the worst public health crisis in a century,” said Adm Rachel Levine, M.D. “Bringing together the resources and expertise of federal, state, and local partners, patients, providers, researchers, and the business sector to answer the American peoples most urgent calls to action.”
Background on the Office of Long COVID Research and Practice:
The Office of Long COVID Research will be located within HHS’s Office of the Assistant Secretary for Health under the leadership of the HHS Assistant Secretary for Health, Admiral Rachel Levine. The Office is charged with on-going coordination of the whole-of-government response to the longer-term effects of COVID-19, including Long COVID and associated conditions and the implementation of the National Research Action Plan on Long COVID - PDF and the Services and Supports for Longer-Term Impacts of COVID-19 - PDF. Currently 14 federal departments engage on Long COVID, including over a dozen HHS Operating and Staff Divisions with a goal to reduce the impacts of Long COVID by improving quality of life for people living with Long COVID and reducing disparities related to Long COVID.
EXPERTS ALSO SUGGEST LONG COVID PATIENTS AND THEIR FAMILIES CREATE A FINANCIAL PLAN TO PREPARE FOR A LENGTHY ILLNESS.
This is like saying the solution to a car with no fuel in the tank is to just keep turning over the starter.— Treatments for “brain fog” and other cognitive problems. They include Posit Science Corp.’s BrainHQ cognitive training program, another called PASC-Cognitive Recovery by New York City’s Mount Sinai Health System, and a Soterix Medical device that electrically stimulates brain circuits.
'...from some patient groups worried...'A more controversial study of exercise intolerance and fatigue also is planned, with NIH seeking input from some patient groups worried that exercise may do more harm than good for certain long COVID sufferers.
NIH said:Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months.
Treatments will include drugs, biologics, medical devices and other therapies. The trials are designed to evaluate multiple treatments simultaneously to identify more swiftly those that are effective.
Part of the NIH’s Researching COVID to Enhance Recovery (RECOVER) Initiative, the trials were informed by findings from other RECOVER research over the past two years and focus on several of the symptoms described as most burdensome by people experiencing long COVID.
With its complementary research efforts, RECOVER has positioned NIH to design and conduct trials that have the potential to provide long COVID patients who experience varying symptoms with relief sooner than any individual study can alone.